• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioCryst Pharmaceuticals Inc

+ Add to Watchlist


12.5400 USD 0.0200 0.16%

As of 20:10:00 ET on 08/01/2014.

Snapshot for BioCryst Pharmaceuticals Inc (BCRX)

Open: 12.4600 Day's Range: 11.9700 - 12.7500 Volume: 958,326
Previous Close: 12.5200 52wk Range: 4.5500 - 13.3300 1-Yr Rtn: +783.10%

Stock Chart for BCRX

No chart data available.
  • BCRX:US 12.5400
  • 1D
  • 1M
  • 1Y
Interactive BCRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BCRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6534
Est. EPS (USD) (12/2014) -0.7590
Est. PEG Ratio -
Market Cap (M USD) 897.55
Shares Outstanding (M) 71.57
30 Day Average Volume 1,303,629
Price/Book (mrq) -
Price/Sale (ttm) 42.6483
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BCRX

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases & cancer. The Company has late-stage compounds in development & continues to discover additional compounds & to progress them to meet the unmet medical needs of patients and physicians.

Jon P StonehousePresident/CEOThomas R Staab II "Tom"Senior VP/CFO/Acctg Ofcr
William P SheridanSenior VP/Chief Medical OfcrYarlagadda S BabuSenior VP: Drug Discovery
More Company Profile & Key Executives for BCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil